Dalton Chemical Laboratories Inc.

Dalton Pharma Services launches expanded medicinal chemistry services
September 2006

Dalton Pharma Services announces completion of its GMP Oligonucleotide manufacturing facility
April 2006

Dalton Announces operating name change
April 2005

Dalton Chemical Labs Inc. completes it's $1.4 million expansion to it's facilities.
October 2004

Stellar Inc. Moves It's Manufacturing To Dalton Inc.
May 2004

Accelerating Drug Development
January 2004

Race on to realize value of SARS patent.
May 2003

CEOs talk: From job security to youth mobility, six Canadian CEOs share their retention strategies.
May 2003

The fine art of Canadian conversation.
March 2003

Triad's biotech identity is beginning to emerge.
June 2002

Key questions to ask when outsourcing pre-clinical development services.
June 2002

Making Molecules
Dalton Chemical has the knack for creating elusive molecules.
June 2002

Lorus receives fast track designation from FDA for Virulizin for the treatment of pancreatic cancer.
June 4th, 2002

Dalton Chemical Laboratories Inc. is to manufacture drug for Lorus Therapeutics.
March 12, 2001

Dalton Chemical Laboratories ... On the Move!
April 2000

Peptide Synthesis Launch
July 1999